跳至主要内容
临床试验/CTRI/2018/06/014386
CTRI/2018/06/014386尚未招募未知

Antenatal magnesium sulphate for neuroprotection in preterm infants : An open label randomized control trial

PGIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Gestational age less than or equal to 32 weeks
  • 2. Singleton or multiple pregnancy at risk for preterm delivery within the next 24 hours
  • 3.Active preterm labor with cervix 4â??8 cm dilated or preterm premature rupture of membranes or Indicated preterm birth within the next 24 hours

排除标准

  • 1.Maternal contraindications to receiving magnesium sulfate like renal failure, cardiac arrhythmia, myasthenia gravis, hypersensitive to drug, heart block, diabetic coma, electrolyte disorder
  • 2.Preeclampsia, eclampsia
  • 3.Fetal distress, abruptio placenta, severe antepartum hemorrhage where urgent delivery is indicated.
  • 4.Precipitate labor
  • 5.Chorioamnionitis
  • 6.Major fetal abnormalities
  • 7.Intrauterine fetal death

研究者

发起方
PGIMS

相似试验

Role of Magnesium suplhate to mother in protecting... | 临床试验